Impact of vulvovaginal atrophy therapies on postmenopausal women's quality of life in the CRETA study measured by the Cervantes scale.

Objective: To assess the correlation of different vulvovaginal atrophy therapeutic options with the quality of life of postmenopausal women.

Study Design: The CRETA study is a descriptive, observational, cross-sectional, multicenter study designed to measure, besides treatment satisfaction and adherence, the quality of life of postmenopausal women diagnosed with vulvovaginal atrophy in 29 hospitals and centers across Spain.

Main Outcome Measures: The study enrolled postmenopausal women currently receiving treatment with vaginal moisturizers, local estrogen therapy or ospemifene.

Experience with ospemifene in patients with vulvovaginal atrophy treated with laser therapy: case studies.

Vaginal laser therapy is a non-hormonal treatment option for vulvovaginal atrophy (VVA), a component of the genitourinary syndrome of menopause. Through a microablative and/or thermal effect on atrophic vaginal epithelium, laser therapy activates growth factors that increase vascularity and collagen production. Laser and ospemifene are complementary treatments: the laser's effects on intra- and extracellular water are supported by the activity of ospemifene at estrogen receptors to restore vaginal epithelium and natural lubrication.

Assessment of female prevalence of overactive bladder (OAB) in Barcelona using a self-administered screening questionnaire: the Cuestionario de Autoevaluación del Control de la Vejiga (CACV).

Introduction And Hypothesis: Overactive bladder (OAB) syndrome is common urological condition, usually underdiagnosed and difficult to identify. The screening of lower urinary tract symptoms (LUTS) through patient self-administered questionnaires can be useful not only for timely identification of these patients but to implement early interventions for symptoms and their implication in a patients' quality of life (QOL). Our objective was to assess the prevalence of OAB symptoms in patients attending general gynecology units in Barcelona, Spain, through a self-administered screening questionnaire.

Vaginal hysterectomy in non-prolapsed uteruses: "no scar hysterectomy".

Introduction And Hypothesis: Traditionally, vaginal hysterectomy (VH) has been limited to cases of uterine prolapse, despite the fact that vast worldwide literature has demonstrated its applicability in other common benign diseases, such as uterine fibromatosis and abnormal uterine bleeding, with excellent outcomes.

Methods: Such outstanding results have made this procedure one of the most useful and advantageous alternatives when compared to the abdominal and laparoscopic routes.

Results: Currently, VH (an ancient procedure) does not represent a first-line alternative.